1,943
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Lung function and side effects of Aspirin desensitization: a real world study

ORCID Icon, ORCID Icon, , ORCID Icon, , , ORCID Icon & show all
Article: 1869408 | Received 17 Aug 2020, Accepted 21 Dec 2020, Published online: 11 Jan 2021

References

  • Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res. 2011 Jan;3(1):3–7.
  • Hirschberg G. Anaphylactoid reaction to aspirin (1902). Allergy Proc. 1990 Sep-Oct;115:249–250. discussion 251–2.
  • Widal F, Abrami P, Lermoyez J. First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)–1922 (with a note on aspirin desensitization). J Asthma. 1987;24(5):297–300.
  • Velazquez JR, Teran LM. Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology clinical reviews in allergy & immunology. Totowa. 2013 Aug;45(1):75–86.
  • Roca-Ferrer J, Pérez-Gonzalez M, Garcia-Garcia FJ, et al. Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics. Respirology. 2013 May;18(4):711–717.
  • Doña I, Barrionuevo E, Salas M, et al. NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs. Sci Rep. 2018 Nov 12;8(1):16710.
  • Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006 Oct;118(4):773–786. quiz 787–8.
  • Li KL, Lee AY, Abuzeid WM. Aspirin exacerbated respiratory disease: epidemiology, pathophysiology, and management. Med Sci (Basel). 2019 Mar 17;7(3):pii: E45.
  • Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: european position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12.
  • Kennedy JL, Stoner AN, Borish L. Aspirin-exacerbated respiratory disease: prevalence, diagnosis, treatment, and considerations for the future. Am J Rhinol Allergy. 2016 Nov 1;30(6):407–413.
  • Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol. 1980 Jul;66(1):82–88.
  • Ibrahim C, Singh K, Tsai G, et al. A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. Allergy Asthma Clin Immunol. 2014 Dec 11;10(1):64.
  • Ledford DK, Lockey RF. Aspirin or nonsteroidal anti-inflammatory drug-exacerbated chronic rhinosinusitis. Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):590–598.
  • Forer B, Kivity S, Sade J, et al. Aspirin desensitization for ASA triad patients–prospective study of the rhinologist`s perspective. Rhinology. 2011 Mar;49(1):95–99.
  • Xu JJ, Sowerby L, Rotenberg BW. Aspirin desensitization for aspirin-exacerbated respiratory disease (Samter’s Triad): a systematic review of the literature. Int Forum Allergy Rhinol. 2013;3(11):915–920.
  • Macy E, Bernstein JA, Castells MC, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol. 2007 Feb;98(2):172–174.
  • White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018 Sep 13;379(11):1060–1070. Review.
  • Chang JE, Chin W, Simon R. Aspirin-sensitive asthma and upper airway diseases. Am J Rhinol Allergy. 2012;26(1):27–30.
  • Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2007;119(1):157–164.
  • Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy. 2018 Sep 14. DOI:https://doi.org/10.1111/all.13599.
  • American Thoracic Society. Statement on standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136(1):225–244.
  • Kainu A, Pallasaho P, Piirilä P, et al. Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study. Prim Care Respir J. 2013;22(1):64–71.
  • Makowska JS, Olszewska-Ziąber A, Bieńkiewicz B, et al. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine. Allergy Asthma Proc. 2016;37(3):216–224.
  • McGregor MC, Krings JG, Nair P, et al. Role of biologics in asthma. Am J Respir Crit Care Med. 2019 Feb 15;199(4):433–445.
  • Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019 Dec;74(12):2312–2319. Epub 2019 Jul 15.